+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomics Market Size, Share & Trends Analysis Report by Application & Technology (Functional Genomics, Epigenomics), Deliverable (Products, Services), End-use (Clinical Research, Hospital & Clinics), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 200 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4599555
Description Jump to:
The global genomics market size is expected to reach USD 94.86 billion by 2030, according to the report. The market is expected to register a CAGR of 16.5% in the forecast period owing to the increasing demand for novel therapeutic and research applications in genomics. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics’ barcode technology to screen single cells using CRISPR libraries.

Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.

Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual’s genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.

The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.

One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.

Genomics Market Report Highlights

  • The overall growth of the genomics market is attributed to the rising dependence of novel therapeutics for genetic disorders and cancers on genomics-based understanding
  • Functional genomics held the largest market share in the year 2023, owing to the demand for rising applications in diagnostics and gene therapy. Biomarker discovery is anticipated to be the fastest-growing segment in the forecast period due to rising applications of biomarkers in disease and therapeutics research
  • North America dominated the market in 2023 due to the presence of key players and rising support from the government and research institutes to advance the research on Genomics in the region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Application & Technology
1.2.2. Deliverables
1.2.3. End use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing integration of genomics data into clinical workflows
3.3.1.1.1. More targeted and personalized healthcare
3.3.1.1.2. Growth of newborn genetic screening programs
3.3.1.1.3. Advancements in noninvasive cancer screening
3.3.1.1.4. Military genomics
3.3.1.2. Technological advances to facilitate genomic R&D
3.3.1.2.1. Emergence of advanced genome editing techniques
3.3.1.2.2. Integration of new data streams
3.3.1.2.3. RNA biology
3.3.1.2.4. Single-cell biology
3.3.1.3. Rising adoption of DIRECT-TO-CONSUMER genomics
3.3.1.4. Success of genetic tools in agrigenomics
3.3.1.5. Increasing participation of different companies
3.3.1.6. Increase in government role and funding in genomics
3.3.2. Market Restraint Analysis
3.3.2.1. Issues regarding intellectual property protection, data management, and public policies
3.3.2.2. Dearth of Public databases and personnel knowledge on machine learning algorithms
3.4. Industry Analysis Tools
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.4.2. Porter's Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Genomics Market: Application & Technology Business Analysis
4.1. Genomics Market: Application & Technology Market Share Analysis
4.2. Genomics Market Estimates & Forecast, By Application & Technology (USD Million)
4.3. Functional Genomics
4.3.1. Global Functional Genomics Market, 2018 - 2030 (USD Million)
4.3.2. Transfection
4.3.2.1. Global Transfection Market, 2018 - 2030 (USD Million)
4.3.3. Real-Time PCR
4.3.3.1. Global Real-Time PCR Market, 2018 - 2030 (USD Million)
4.3.4. RNA Interference
4.3.4.1. Global RNA Interference Market, 2018 - 2030 (USD Million)
4.3.5. Mutational Analysis
4.3.5.1. Global Mutational Analysis Market, 2018 - 2030 (USD Million)
4.3.6. SNP Analysis
4.3.6.1. Global SNP Analysis Market, 2018 - 2030 (USD Million)
4.3.7. Microarray Analysis
4.3.7.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
4.4. Epigenomics
4.4.1. Global Epigenomics Market, 2018 - 2030 (USD Million)
4.4.2. Bisulfite Sequencing
4.4.2.1. Global Bisulfite Sequencing Market, 2018 - 2030 (USD Million)
4.4.3. Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
4.4.3.1. Global Chromatin Immunoprecipitation (ChIP & ChIP-Seq) Market, 2018 - 2030 (USD Million)
4.4.4. Methylated DNA Immunoprecipitation (MeDIP)
4.4.4.1. Global Methylated DNA Immunoprecipitation (MeDIP) Market, 2018 - 2030 (USD Million)
4.4.5. High-Resolution Melt (HRM)
4.4.5.1. Global High-Resolution Melt (HRM) Market, 2018 - 2030 (USD Million)
4.4.6. Chromatin Accessibility Assays
4.4.6.1. Global Chromatin Accessibility Assays Market, 2018 - 2030 (USD Million)
4.4.7. Microarray Analysis
4.4.7.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
4.5. Pathway Analysis
4.5.1. Global Pathway Analysis Market, 2018 - 2030 (USD Million)
4.5.2. Bead-Based Analysis
4.5.2.1. Global Bead-Based Analysis Market, 2018 - 2030 (USD Million)
4.5.3. Microarray Analysis
4.5.3.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
4.5.4. Real-time PCR
4.5.4.1. Global Real-time PCR Market, 2018 - 2030 (USD Million)
4.5.5. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
4.5.5.1. Global Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Market, 2018 - 2030 (USD Million)
4.6. Biomarker Discovery
4.6.1. Global Biomarker Discovery Market, 2018 - 2030 (USD Million)
4.6.2. Mass Spectrometry
4.6.2.1. Global Mass Spectrometry Market, 2018 - 2030 (USD Million)
4.6.3. Real-time PCR
4.6.3.1. Global Real-time PCR Market, 2018 - 2030 (USD Million)
4.6.4. Microarray Analysis
4.6.4.1. Global Microarray Analysis Market, 2018 - 2030 (USD Million)
4.6.5. Statistical Analysis
4.6.5.1. Global Statistical Analysis Market, 2018 - 2030 (USD Million)
4.6.6. Bioinformatics
4.6.6.1. Global Bioinformatics Market, 2018 - 2030 (USD Million)
4.6.7. DNA Sequencing
4.6.7.1. Global DNA Sequencing Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 5. Genomics Market: Deliverables Business Analysis
5.1. Genomics Market: Deliverables Market Share Analysis
5.2. Genomics Market Estimates & Forecast, By Deliverables (USD Million)
5.3. Products
5.3.1. Global Products Market, 2018 - 2030 (USD Million)
5.3.2. Instruments/Systems/Software
5.3.2.1. Global Instruments/Systems/Software Market, 2018 - 2030 (USD Million)
5.3.3. Consumables & Reagents
5.3.3.1. Global Consumables & Reagents Market, 2018 - 2030 (USD Million)
5.4. Services
5.4.1. Global Services Market, 2018 - 2030 (USD Million)
5.4.2. NGS-based Services
5.4.2.1. Global NGS-based Services Market, 2018 - 2030 (USD Million)
5.4.3. Core Genomics Services
5.4.3.1. Global Core Genomics Services Market, 2018 - 2030 (USD Million)
5.4.4. Biomarker Translation Services
5.4.4.1. Global Biomarker Translation Services Market, 2018 - 2030 (USD Million)
5.4.5. Computational Services
5.4.5.1. Global Computational Services Market, 2018 - 2030 (USD Million)
5.4.6. Others
5.4.6.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 6. Genomics Market: End-use business Analysis
6.1. Genomics Market: End-use Market Share Analysis
6.2. Genomics Market Estimates & Forecast, By End-use (USD Million)
6.3. Clinical Research
6.3.1. Global Clinical Research Market, 2018 - 2030 (USD Million)
6.4. Academic & Government Institutes
6.4.1. Global Academic & Government Institutes Market, 2018 - 2030 (USD Million)
6.5. Hospitals & Clinics
6.5.1. Global Hospitals & Clinics Market, 2018 - 2030 (USD Million)
6.6. Pharmaceutical & Biotechnology Companies
6.6.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 7. Genomics Market: Regional Business Analysis
7.1. Genomics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Genomics Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. U.S. Genomics Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Canada Genomics Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Genomics Market, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. UK Genomics Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Germany Genomics Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. France Genomics Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Italy Genomics Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Spain Genomics Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Denmark Genomics Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Sweden Genomics Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Norway Genomics Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Genomics Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Japan Genomics Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. China Genomics Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. India Genomics Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Australia Genomics Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Thailand Genomics Market, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. South Korea Genomics Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Genomics Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Brazil Genomics Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Genomics Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Argentina Genomics Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Genomics Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. South Africa Genomics Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Saudi Arabia Genomics Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. UAE Genomics Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Kuwait Genomics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Financial Performance
8.2. Participant Categorization
8.2.1. Market Leaders
8.2.1.1. Market share analysis, 2023
8.3. Participant’s Overview
8.3.1. Agilent Technologies
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Technology Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Bio-Rad Laboratories, Inc
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Technology Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. BGI Genomics
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Technology Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Color Genomics, Inc
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Technology Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Danaher Corporation
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Technology Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Eppendorf AG
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Technology Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Eurofins Scientific
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Technology Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. F. Hoffmann-La Roche Ltd.
8.3.8.1. Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Technology Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. GE Healthcare
8.3.9.1. Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Technology Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Illumina, Inc.
8.3.10.1. Overview
8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.10.3. Technology Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Myriad Genetics, Inc
8.3.11.1. Overview
8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.11.3. Technology Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Oxford Nanopore Technologies
8.3.12.1. Overview
8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.12.3. Technology Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Pacific Biosciences of California, Inc
8.3.13.1. Overview
8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.13.3. Technology Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. QIAGEN N.V.
8.3.14.1. Overview
8.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.14.3. Technology Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Quest Diagnostics Incorporated
8.3.15.1. Overview
8.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.15.3. Technology Benchmarking
8.3.15.4. Strategic Initiatives
8.3.16. Thermo Fisher Scientific, Inc
8.3.16.1. Overview
8.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.16.3. Technology Benchmarking
8.3.16.4. Strategic Initiatives
8.3.17. 23andMe, Inc
8.3.17.1. Overview
8.3.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.17.3. Technology Benchmarking
8.3.17.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Expansion
8.4.2. Acquisition
8.4.3. Collaborations
8.4.4. Product/service launch
8.4.5. Partnerships
8.4.6. Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 4 Global genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 5 Global genomics market, by End-use, 2018 - 2030 (USD Million)
Table 6 Global genomics market, by region, 2018 - 2030 (USD Million)
Table 7 North America genomics market, by country, 2018 - 2030 (USD Million)
Table 8 North America genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 9 North America genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 10 North America genomics market, by End-use, 2018 - 2030 (USD Million)
Table 11 U.S. genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 12 U.S. genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 13 U.S. genomics market, by End-use, 2018 - 2030 (USD Million)
Table 14 Canada genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 15 Canada genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 16 Canada genomics market, by End-use, 2018 - 2030 (USD Million)
Table 17 Europe genomics market, by country, 2018 - 2030 (USD Million)
Table 18 Europe genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 19 Europe genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 20 Europe genomics market, by End-use, 2018 - 2030 (USD Million)
Table 21 UK genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 22 UK genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 23 UK genomics market, by End-use, 2018 - 2030 (USD Million)
Table 24 Germany genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 25 Germany genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 26 Germany genomics market, by End-use, 2018 - 2030 (USD Million)
Table 27 France genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 28 France genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 29 France genomics market, by End-use, 2018 - 2030 (USD Million)
Table 30 Italy genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 31 Italy genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 32 Italy genomics market, by End-use, 2018 - 2030 (USD Million)
Table 33 Spain genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 34 Spain genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 35 Spain genomics market, by End-use, 2018 - 2030 (USD Million)
Table 36 Denmark genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 37 Denmark genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 38 Denmark genomics market, by End-use, 2018 - 2030 (USD Million)
Table 39 Sweden genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 40 Sweden genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 41 Sweden genomics market, by End-use, 2018 - 2030 (USD Million)
Table 42 Norway genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 43 Norway genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 44 Norway genomics market, by End-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific genomics market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 48 Asia Pacific genomics market, by End-use, 2018 - 2030 (USD Million)
Table 49 Japan genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 50 Japan genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 51 Japan genomics market, by End-use, 2018 - 2030 (USD Million)
Table 52 China genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 53 China genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 54 China genomics market, by End-use, 2018 - 2030 (USD Million)
Table 55 India genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 56 India genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 57 India genomics market, by End-use, 2018 - 2030 (USD Million)
Table 58 Australia genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 59 Australia genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 60 Australia genomics market, by End-use, 2018 - 2030 (USD Million)
Table 61 Thailand genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 62 Thailand genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 63 Thailand genomics market, by End-use, 2018 - 2030 (USD Million)
Table 64 South Korea genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 65 South Korea genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 66 South Korea genomics market, by End-use, 2018 - 2030 (USD Million)
Table 67 Latin America genomics market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 69 Latin America genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 70 Latin America genomics market, by End-use, 2018 - 2030 (USD Million)
Table 71 Brazil genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 72 Brazil genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 73 Brazil genomics market, by End-use, 2018 - 2030 (USD Million)
Table 74 Mexico genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 75 Mexico genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 76 Mexico genomics market, by End-use, 2018 - 2030 (USD Million)
Table 77 Argentina genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 78 Argentina genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 79 Argentina genomics market, by End-use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa genomics market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa genomics market, by End-use, 2018 - 2030 (USD Million)
Table 84 South Africa genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 85 South Africa genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 86 South Africa genomics market, by End-use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia genomics market, by End-use, 2018 - 2030 (USD Million)
Table 90 UAE genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 91 UAE genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 92 UAE genomics market, by End-use, 2018 - 2030 (USD Million)
Table 93 Kuwait genomics market, by technology & application, 2018 - 2030 (USD Million)
Table 94 Kuwait genomics market, by deliverables, 2018 - 2030 (USD Million)
Table 95 Kuwait genomics market, by End-use, 2018 - 2030 (USD Million)
Table 96 Participant's overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undergoing acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new products/services
Table 102 Key companies undertaking other strategies
List of Figures
Fig. 1 Genomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Related/ancillary market outlook
Fig. 14 Genomics - Industry value chain analysis
Fig. 15 Genomics market driver analysis
Fig. 16 Genomics market restraint analysis
Fig. 17 Genomics market: Porter's analysis
Fig. 18 Genomics market: application & technology outlook and key takeaways
Fig. 19 Genomics market: Application & technology market share analysis, 2022 - 2030
Fig. 20 Global sequencing by Functional Genomics market, 2018 - 2030 (USD Million)
Fig. 21 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
Fig. 22 Global sequencing by Transfection market, 2018 - 2030 (USD Million)
Fig. 23 Global sequencing by SNP analysis market, 2018 - 2030 (USD Million)
Fig. 24 Global sequencing by Mutational analysis market, 2018 - 2030 (USD Million)
Fig. 25 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
Fig. 26 Global sequencing by RNA interference market, 2018 - 2030 (USD Million)
Fig. 27 Global sequencing by Epigenomics market, 2018 - 2030 (USD Million)
Fig. 28 Global sequencing by Bisulfite sequencing market, 2018 - 2030 (USD Million)
Fig. 29 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
Fig. 30 Global sequencing by Chromatin immunoprecipitation (ChIP & ChIP-Seq) market, 2018 - 2030 (USD Million)
Fig. 31 Global sequencing by Methylated DNA immunoprecipitation (MeDIP) market, 2018 - 2030 (USD Million)
Fig. 32 Global sequencing by High resolution melt (HRM) market, 2018 - 2030 (USD Million)
Fig. 33 Global sequencing by Chromatin accessibility assays market, 2018 - 2030 (USD Million)
Fig. 34 Global sequencing by Pathway Analysis market, 2018 - 2030 (USD Million)
Fig. 35 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
Fig. 36 Global sequencing by Bead-based analysis market, 2018 - 2030 (USD Million)
Fig. 37 Global sequencing by Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market, 2018 - 2030 (USD Million)
Fig. 38 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
Fig. 39 Global sequencing by Biomarker Discovery market, 2018 - 2030 (USD Million)
Fig. 40 Global sequencing by DNA sequencing market, 2018 - 2030 (USD Million)
Fig. 41 Global sequencing by Microarray analysis market, 2018 - 2030 (USD Million)
Fig. 42 Global sequencing by Real-time PCR market, 2018 - 2030 (USD Million)
Fig. 43 Global sequencing by Mass spectrometry market, 2018 - 2030 (USD Million)
Fig. 44 Global sequencing by Statistical analysis market, 2018 - 2030 (USD Million)
Fig. 45 Global sequencing by Bioinformatics market, 2018 - 2030 (USD Million)
Fig. 46 Global sequencing by Products market, 2018 - 2030 (USD Million)
Fig. 47 Global sequencing by Services market, 2018 - 2030 (USD Million)
Fig. 48 Global sequencing by Instruments/Systems/Softwares market, 2018 - 2030 (USD Million)
Fig. 49 Global sequencing by Consumables & Reagents market, 2018 - 2030 (USD Million)
Fig. 50 Global sequencing by NGS-based Services market, 2018 - 2030 (USD Million)
Fig. 51 Global sequencing by Core Genomics Services market, 2018 - 2030 (USD Million)
Fig. 52 Global sequencing by Biomarker Translation Services market, 2018 - 2030 (USD Million)
Fig. 53 Global sequencing by Computational Services market, 2018 - 2030 (USD Million)
Fig. 54 Global sequencing by Others market, 2018 - 2030 (USD Million)
Fig. 55 Global sequencing by Pharmaceutical and Biotechnology Companies market, 2018 - 2030 (USD Million)
Fig. 56 Global sequencing by Hospitals and Clinics market, 2018 - 2030 (USD Million)
Fig. 57 Global sequencing by Academic and Government Institutes market, 2018 - 2030 (USD Million)
Fig. 58 Global sequencing by Clinical Research market, 2018 - 2030 (USD Million)
Fig. 59 Global sequencing by Other End-uses market, 2018 - 2030 (USD Million)
Fig. 60 Regional marketplace: Key takeaways
Fig. 61 Regional marketplace: Key takeaways
Fig. 62 North America genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 U.S. key country dynamics
Fig. 64 U.S. genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Canada key country dynamics
Fig. 66 Canada genomics market, 2018 - 2030 (USD Million)
Fig. 67 Europe genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 UK key country dynamics
Fig. 69 UK genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Germany key country dynamics
Fig. 71 Germany genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 France key country dynamics
Fig. 73 France genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Italy key country dynamics
Fig. 75 Italy genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Spain key country dynamics
Fig. 77 Spain genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Denmark key country dynamics
Fig. 79 Denmark genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Sweden key country dynamics
Fig. 81 Sweden genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Norway key country dynamics
Fig. 83 Norway genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Asia-Pacific genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Japan key country dynamics
Fig. 86 Japan genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 China key country dynamics
Fig. 88 China genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 India key country dynamics
Fig. 90 India genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Australia key country dynamics
Fig. 92 Australia genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 93 Thailand key country dynamics
Fig. 94 Thailand genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 95 South Korea key country dynamics
Fig. 96 South Korea genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 Latin America genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 98 Brazil key country dynamics
Fig. 99 Brazil genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 100 Mexico key country dynamics
Fig. 101 Mexico genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 102 Argentina key country dynamics
Fig. 103 Argentina genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 104 MEA genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 105 South Africa key country dynamics
Fig. 106 South Africa genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 107 Saudi Arabia key country dynamics
Fig. 108 Saudi Arabia genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 109 UAE key country dynamics
Fig. 110 UAE genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 111 Kuwait key country dynamics
Fig. 112 Kuwait genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 113 Key company categorization
Fig. 114 Company market positioning
Fig. 115 Market participant categorization
Fig. 116 Strategy framework

Companies Profiled

  • Agilent Technologies
  • Bio-Rad Laboratories, Inc
  • BGI Genomics
  • Color Genomics, Inc
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc
  • 23andMe, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages200
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 32.65 Billion
Forecasted Market Value ( USD ) by 2030 $ 94.86 Billion
Compound Annual Growth Rate16.5%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Site Specific and Global Epigenomic Editing. Principles and Applications. Translational Epigenetics Volume 33 - Product Image

Site Specific and Global Epigenomic Editing. Principles and Applications. Translational Epigenetics Volume 33

  • Book
  • Global
Precision Genomic Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Equipment), By Application (Oncology, Cardiovascular Diseases), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Precision Genomic Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Equipment), By Application (Oncology, Cardiovascular Diseases), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Optical Genome Mapping Market Size, Share & Trends Analysis Report By Product & Service, By Technique (Structural Variant Detection, Genome Assembly), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Optical Genome Mapping Market Size, Share & Trends Analysis Report By Product & Service, By Technique (Structural Variant Detection, Genome Assembly), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Genomics Market by Product & Service, Technology, End-User, Application - Global Forecast 2025-2030 - Product Image

Genomics Market by Product & Service, Technology, End-User, Application - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Consumer Genomics Market by Product & Service, Technology, Application - Global Forecast 2025-2030 - Product Image

Consumer Genomics Market by Product & Service, Technology, Application - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.